Ultragenyx Pharma Price Target Raised to $75.00/Share From $72.00 by Wells Fargo
Ultragenyx Pharma Price Target Raised to $75.00/Share From $72.00 by Wells Fargo
威爾斯·法戈將Ultragenyx Pharma的價格目標從72.00美元/股上調至75.00美元/股
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊